(2S)-2-[(4-羟基-4-氧代丁酰基)氨基]戊烷二酸 | 33981-72-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: (2S)-2-[(4-羟基-4-氧代丁酰基)氨基]戊烷二酸
• 英文名称: N-succinoyl-L-glutamic acid
• 英文别名: N-succinyl-L-glutamic acid；N2-succinylglutamic acid；Suc-Glu；N-(3-carboxy-propionyl)-L-glutamic acid；N-(3-Carboxy-propionyl)-L-glutaminsaeure；(2S)-2-(3-Carboxypropanoylamino)pentanedioic acid
• CAS: 33981-72-5
• 化学式: C₉H₁₃NO₇
• 分子量: 247.205
• InChiKey: JCNBNOQGFSXOML-YFKPBYRVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.5
• 重原子数：
  17
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  141
• 氢给体数：
  4
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  (2S)-2-[(4-羟基-4-氧代丁酰基)氨基]戊烷二酸 在 氯化亚砜 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以94%的产率得到(4-chloro-4-oxobutanoyl)-L-glutamoyl dichloride
  参考文献：
  名称：

  [EN] POLYAMIDE MICROCAPSULES
  [FR] MICROCAPSULES DE POLYAMIDE

  摘要：

  本发明涉及聚酰胺微胶囊。制备聚酰胺微胶囊的方法也是本发明的目标。包括这些微胶囊的香料组合物和消费品，特别是家居护理或个人护理产品的香气消费品，也是本发明的一部分。

  公开号：

  WO2021254931A1
• 作为产物：
  描述：

  (2S)-(3-carboxypropionylamino)pentanedioic acid dibenzyl ester 在 palladium on activated charcoal ammonium formate 作用下， 以 甲醇 为溶剂， 反应 0.42h， 以30%的产率得到(2S)-2-[(4-羟基-4-氧代丁酰基)氨基]戊烷二酸
  参考文献：
  名称：

  Synthesis of acyclic and dehydroaspartic acid analogs of Ac-Asp-Glu-OH and their inhibition of rat brain N-acetylated .alpha.-linked acidic dipeptidase (NAALA dipeptidase)

  摘要：

  The following structural and conformationally constrained analogues of Ac-Asp-Glu-OH (1) were synthesized: Ac-Glu-Glu-OH (2), Ac-D-Asp-Glu-OH (3), Ac-Glu-Asp-OH (4), Ac-Asp-Asp-OH (5), Ac-Asp-3-aminohexanedioic acid (6), Ac-3-amino-3-(carboxymethyl)propanoyl-Glu-OH (7), N-succinyl-Glu-OH (8), N-maleyl-Glu-OH (9), N-fumaryl-Glu-OH (10), and Ac-delta ZAsp-Glu-OH (11). These analogues were evaluated for their ability to inhibit the hydrolysis of Ac-Asp-[3,4-3H]-Glu-OH by N-acetylated alpha-linked acidic dipeptidase (NAALA dipeptidase) in order to gain some insight into the structural requirements for the inhibition of this enzyme. Analogues 4-6 and 9 were very weak inhibitors of NAALA dipeptidase (Ki greater than 40 microM), while 2, 3, and 7 with Ki values ranging from 3.2-8.5 microM showed intermediate inhibitory activity. The most active inhibitors of NAALA dipeptidase were compounds 8, 10, and 11 with Ki values of 0.9, 0.4, and 1.4 microM, respectively. These results suggest that the relative spacing between the side chain carboxyl and the alpha-carboxyl group of the C-terminal residue may be important for binding to the active site of the enzyme. They also indicate that the chi 1 torsional angle for the aspartyl residue is in the vicinity of 0 degrees.

  DOI：

  10.1021/jm00172a009

文献信息

• [EN] PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS AS DIAGNOSTIC AND RADIONUCLIDE THERAPEUTIC AGENTS<br/>[FR] INHIBITEURS DE L'ANTIGÈNE MEMBRANAIRE SPÉCIFIQUE DE LA PROSTATE (PSMA) EN TANT QU'AGENTS DIAGNOSTIQUES ET AGENTS THÉRAPEUTIQUES DE TYPE RADIONUCLÉIDES
  申请人：FIVE ELEVEN PHARMA INC

  公开号：WO2020220023A1

  公开（公告）日：2020-10-29

  The present disclosure relates to compounds according to Formula I. These compounds display very good binding affinities to the PSMA binding sites. They comprise a radioactive isotope or a chelating moiety that can be labeled with a radioactive metal such as [68Ga]or [177Lu]. The present disclosure also relates to pharmaceutical compositions comprising a pharmaceutical acceptable carrier and a compound of Formula I or a complex thereof, or a pharmaceutically acceptable salt thereof.

  本公开涉及符合式I的化合物。这些化合物显示出对PSMA结合位点非常好的结合亲和力。它们包括一个放射性同位素或一个能够用放射性金属标记的螯合基团，如[68Ga]或[177Lu]。本公开还涉及包括药用可接受载体和符合式I的化合物或其复合物，或其药用可接受盐的制药组合物。
• Probe compound for detecting and isolating enzymes and means and methods using the same
  申请人：Helmholtz-Zentrum für Infektionsforschung GmbH

  公开号：EP2230312A1

  公开（公告）日：2010-09-22

  The present invention relates to a probe compound that can comprise any substrate or metabolite of an enzymatic reaction in addition to an indicator component, such as, for example, a fluorescence dye, or the like. Moreover, the present invention relates to means for detecting enzymes in form of an array, which comprises any number of probe compounds of the invention which each comprise a different metabolite of interconnected metabolites representing the central pathways in all forms of life. Moreover, the present invention relates to a method for detecting enzymes involving the application of cell extracts or the like to the array of the invention which leads to reproducible enzymatic reactions with the substrates. These specific enzymatic reactions trigger the indicator (e.g. a fluorescence signal) and bind the enzymes to the respective cognate substrates. Moreover, the invention relates to means for isolating enzymes in form of nanoparticles coated with the probe compound of the invention. The immobilisation of the cognate substrates or metabolites on the surface of nanoparticles by means of the probe compounds allows capturing and isolating the respective enzyme, e.g. for subsequent sequencing.

  本发明涉及一种探针化合物，它可以包括酶反应的任何底物或代谢物，此外还包括指示成分，例如荧光染料或类似物。此外，本发明还涉及以阵列形式检测酶的方法，该阵列由任意数量的本发明探针化合物组成，每种探针化合物由代表所有生命形式中中心途径的相互关联的代谢物中的不同代谢物组成。此外，本发明还涉及一种检测酶的方法，该方法涉及将细胞提取物或类似物应用于本发明的阵列，从而导致与底物发生可重复的酶反应。这些特定的酶反应会触发指示剂（如荧光信号），并将酶与各自的同源底物结合。此外，本发明还涉及以涂覆有本发明探针化合物的纳米颗粒形式分离酶的方法。通过探针化合物将同源底物或代谢物固定在纳米颗粒表面，可以捕获和分离相应的酶，例如用于后续测序。
• Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy
  申请人：Five Eleven Pharma Inc.

  公开号：US10688200B2

  公开（公告）日：2020-06-23

  The present invention relates to compounds according to Formula I and Formula IV. These compounds display very good binding affinities to the PSMA binding sites. They can be labeled with [68Ga]GaCl3 with high yields and excellent radiochemical purity. The present invention also relates to pharmaceutical compositions comprising a pharmaceutical acceptable carrier and a compound of Formula I or Formula IV, or a pharmaceutically acceptable salt thereof.

  本发明涉及符合式 I 和式 IV 的化合物。这些化合物与 PSMA 结合位点有很好的结合亲和力。它们可以用[68Ga]GaCl3标记，产量高，放射化学纯度极佳。本发明还涉及药物组合物，其中包含药学上可接受的载体和式 I 或式 IV 的化合物或其药学上可接受的盐。
• AUBERT; MILLET; PINEAU, Comptes rendus hebdomadaires des seances de l'Academie des sciences, 1959, vol. 249, p. 1956 - 1958
  作者：AUBERT、MILLET、PINEAU、MILHAUD

  DOI：——

  日期：——
• SUBASINGHE, NALIN;SCHULTE, MARVIN;CHAN, MICHAEL Y. -M.;ROON, ROBERT J.;KO+, J. MED. CHEM., 33,(1990) N0, C. 2734-2744
  作者：SUBASINGHE, NALIN、SCHULTE, MARVIN、CHAN, MICHAEL Y. -M.、ROON, ROBERT J.、KO+

  DOI：——

  日期：——